HealthTech Disease Self-Management Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for HealthTech Disease Self-Management Platforms
1.1 - About HealthTech Disease Self-Management Platforms sector
Companies in HealthTech Disease Self-Management Platforms deliver connected care solutions that empower patients with chronic conditions to capture physiologic data and receive guidance, while enabling clinicians to monitor remotely and intervene earlier. Offerings combine connected devices, mobile apps, personalized coaching, and provider dashboards to improve outcomes, reduce costs, and support reimbursable programs such as Remote Patient Monitoring and Chronic Care Management.
Vendors typically provide remote patient monitoring platforms that ingest device data from glucose meters, blood pressure cuffs, wearables, and home sensors into provider dashboards with triage workflows and alerts. Many offer digital therapeutics with behavior‑change coaching, AI‑driven risk stratification, care coordination and call center services, EHR integration and billing modules for RPM reimbursement, as well as diagnostic equipment interfaces and compatible consumables for condition‑specific assessments.
Primary customers include hospitals and physician practices managing chronic disease populations, payer and ACO care management teams, and home health or aging services providers. These solutions drive earlier clinical intervention, higher patient engagement and adherence, improved glycemic and blood pressure control, reduced readmissions and total cost of care, and incremental revenue through CMS‑reimbursable RPM and CCM programs, while streamlining care team workflows.
2. Buyers in the HealthTech Disease Self-Management Platforms sector
2.1 Top strategic acquirers of HealthTech Disease Self-Management Platforms companies
CoachCare
HQ: United States
Website
- Description: Provider of remote patient monitoring and virtual health software that enables physicians, physician groups and health systems to generate new reimbursement revenue and improve patient outcomes through connected devices, real-time physiologic data transmission, provider dashboards and telehealth capabilities, supporting 3,000+ clinics without requiring additional staff.
- Key Products:
- Remote Patient Monitoring Platform: Collects physiologic data via connected devices, streams it in real time to clinicians, enabling early interventions and Medicare RPM reimbursement to drive substantial recurring revenue
- Provider Dashboard: Centralized interface aggregates RPM data across conditions, surfaces actionable insights, simplifies compliance documentation, and automates billing workflows so practices add revenue without hiring extra staff
- Connected Devices Integration: Supports approved health devices for cardiology, endocrinology, bariatric and obesity care, automatically syncing measurements to the platform for continuous chronic and acute condition management
- Virtual Health Platform: Combines telehealth
- RTM
- BHI and CHI capabilities with video and messaging to deliver comprehensive remote care across 250-plus provider organizations.
- Rationale: Provider of Remote Patient Monitoring platform streaming vitals, Provider Dashboard automating billing, and Connected Devices integration for cardiometabolic care.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HealthTech Disease Self-Management Platforms sector
M&A buyer group 1: Remote Patient Monitoring
19 companies
View group →
Description: Companies in the Digital Health Remote Patient Monitoring Platforms category provide cloud-based systems that connect at-home patients to clinical teams through connected devices and secure data pipelines. They aggregate physiologic signals, surface actionable insights, and orchestrate care workflows, enabling earlier intervention and reimbursable remote care. Offerings typically span device management, EHR integration, patient engagement, and analytics, helping providers scale virtual care programs with measurable clinical and financial impact.
Huma
HQ: United Kingdom
- Type: N/A
- Employees: ●●●●●
- Description: Provider of AI-driven digital health solutions that include a cloud platform for rapidly building regulated health apps, remote patient monitoring, virtual wards and clinical trial tools, plus AI modules that automate documentation, triage and care workflows to optimise patient outcomes.
- Key Products:
- Huma Cloud Platform: Highly configurable, flexible, disease-agnostic cloud infrastructure offering code-free configuration, multi-device connectivity and hosting of AI/ML models with multiple regulatory clearances for rapid digital health solution deployment
- Remote Patient Monitoring Programmes: Programmes capture real-world health data, enable continuous remote monitoring and self-management, empowering proactive, preventative care while reducing hospital burden
- Companion Apps: Mobile companion applications integrate with the platform to support online or face-to-face consultations, deliver personalised insights and guide patients through their health journeys
- Risk Assessment Tools & AI Algorithms: AI-powered, including generative AI, algorithms analyse patient histories to generate personalised risk assessments, predictive insights and optimise treatment outcomes for clinicians and researchers.
🔒
🔒
🔒
View all 19 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in HealthTech Disease Self-Management Platforms sector
3.1 - Buyout funds in the HealthTech Disease Self-Management Platforms sector
2.2 - Strategic buyer groups for HealthTech Disease Self-Management Platforms sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HealthTech Disease Self-Management Platforms companies
4.2 - Public trading comparable groups for HealthTech Disease Self-Management Platforms sector
Valuation benchmark group 1: Medical Monitoring and Respiratory Device Companies
11 companies
View group →
Description: Companies in this trading comparables group manufacture and supply clinical patient monitoring and respiratory care devices used across acute and ambulatory settings. Their business models combine capital equipment placement with recurring revenue from disposables, software, and service. They are comparable given shared regulatory pathways, hospital procurement dynamics, connectivity to clinical workflows, and similar revenue mix between hardware, consumables, and digital health monitoring platforms.
ResMed
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of cloud-connectable medical devices and digital health technologies aimed at diagnosing, treating, and managing sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, thereby enhancing patient health and quality of life.
- Key Products:
- CPAP Devices: Cloud-connectable CPAP machines for sleep apnea treatment
- CPAP Masks: Comfortable and effective masks for CPAP therapy
- Respiratory Care Devices: Ventilators and bilevel devices for respiratory support
- Digital Health Solutions: Software platforms for managing respiratory conditions
- Accessories: Tubing, humidifiers, and other CPAP accessories for enhanced therapy
🔒
🔒
🔒
View all 11 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →